RIL
MBX

Rothschild Investment LLC’s MBX Biosciences MBX Stock Holding History

Rothschild Investment LLC’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15K Buy
39
+15
+63% +$524 ﹤0.01% 2729
2026
Q1 		$716 Hold
24
– – ﹤0.01% 3001
2025
Q4 		$757 Buy
24
+4
+20% +$97 ﹤0.01% 2773
2025
Q3 		$350 Hold
20
– – ﹤0.01% 2909
2025
Q2 		$228 Buy
+20
New +$204 ﹤0.01% 2915

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Rothschild Investment LLC's MBX Position: Q2 2026 in Review

Rothschild Investment LLC increased its MBX Biosciences (MBX) stake by 63% in Q2 2026, buying an estimated $524 and bringing the position to 39 shares worth $2.15K. The position accounts for ﹤0.01% of the portfolio, ranked #2729.

Rothschild Investment LLC first reported a position in MBX in Q2 2025 and has held it in 5 quarters since. 172 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • Rothschild Investment LLC held 39 shares of MBX Biosciences worth $2.15K as of Q2 2026.
  • Rothschild Investment LLC bought 15 MBX Biosciences shares in Q2 2026, an estimated $524.
  • MBX Biosciences made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2729 holding.
  • Rothschild Investment LLC first reported a position in MBX Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 172 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.